FDA Airs ‘Concerns’ Over IP Barriers
US Agency’s Patent Concerns Include Thickets, Product Hopping And Evergreening
Senators press for sharing of FDA applications with PTO as Woodcock letter seeks collaboration on everything from PTAB to patent term extensions to ‘possible misuse of the patent system.’
